Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Evaluation of the Novel Silq ClearTract Catheter in Patients With Chronic Urinary Retention

NCT: NCT05931887 · COMPLETED

NCT IDNCT05931887
StatusCOMPLETED
Start Date2023-07-26
Completion2026-04-18

Brief Summary

To assess the ability of the Silq ClearTract™ 100% Silicone 2-Way Foley Catheter to reduce catheter associated complications in subjects that require a long-term indwelling Foley catheter when compared to other commercially available Foley catheters.

Frequently Asked Questions

What is Evaluation of the Novel Silq ClearTract Catheter in Patients With Chronic Urinary Retention?

Evaluation of the Novel Silq ClearTract Catheter in Patients With Chronic Urinary Retention is a clinical trial registered under NCT05931887. Current status: COMPLETED.

What is the status of NCT05931887?

The current status of NCT05931887 (Evaluation of the Novel Silq ClearTract Catheter in Patients With Chronic Urinary Retention) is: COMPLETED.

When did Evaluation of the Novel Silq ClearTract Catheter in Patients With Chronic Urinary Retention start?

Evaluation of the Novel Silq ClearTract Catheter in Patients With Chronic Urinary Retention started on 2023-07-26.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑